Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Darbepoetin Alfa vs Epoetin Alfa for Anemia in Cancer Chemotherapy
NCT00070382Phase 3Completed
- Sponsor
- UCLA Jonsson Comprehensive Cancer Center
- Start
- Aug 2003
- Primary completion
- Nov 2003
- Modality
- Erythropoietins, Colony Stimulating Factors
- Countries
- 1
01
Overview
A Phase 3 trial of darbepoetin alfa in anemia, sponsored by UCLA Jonsson Comprehensive Cancer Center. Started Aug 2003; status: completed.
02
Drugs
darbepoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00070382.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00070382.